Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Evan Stein

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Stein, Evan

Item TypeName
Concept Proprotein Convertases
Academic Article Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).
Academic Article Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9.
Academic Article Evolocumab in hyperlipidemia.
Academic Article Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future.
Academic Article Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Academic Article MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
Academic Article Potential of proprotein convertase subtilisin/kexin type 9 based therapeutics.
Academic Article Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
Academic Article Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.
Academic Article Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials.
Academic Article What role will proprotein convertase subtilisin/kexin type 9 inhibitors play in hyperlipidemia management?
Academic Article Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
Academic Article Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.
Academic Article PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all : Editorial to: "Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/Dl or Higher" by Henry N. Ginsberg et Al.
Academic Article Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial.
Academic Article PCSK9 and diabetes: is there a link?
Academic Article PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.
Academic Article PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.
Academic Article Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
Academic Article Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia.
Academic Article Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.
Academic Article Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy.
Academic Article Other therapies for reducing low-density lipoprotein cholesterol: medications in development.
Academic Article Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
Academic Article Insights into PCSK9, low-density lipoprotein receptor, and low-density lipoprotein cholesterol metabolism: of mice and man.
Academic Article Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1).
Academic Article Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.

Search Criteria
  • Proprotein Convertases